Orna Therapeutics
Anju Kadian is a skilled professional in the field of cellular and molecular biology, currently serving as a Senior Research Associate at Orna Therapeutics since April 2022. Concurrently, Anju holds the position of Postgraduate Associate at Yale University School of Medicine, beginning in April 2021, and previously completed a Research Internship at the same institution in early 2020. Anju's experience also includes community volunteer work at St. Lawrence Seminary High School, where responsibilities included judging a Science Fair, and serving as an Assistant Lecturer at Pi Academy, delivering lectures and training students for medical entrance examinations. Anju's educational background includes a Master of Science in Cell/Cellular and Molecular Biology from the University of New Haven and a Master of Science in Medical Biotechnology from Maharshi Dayanand University, complemented by a Bachelor of Science in Zoology Honours from Delhi University.
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.